Pfizer and biontech receive authorization in the european union for covid-19 vaccine

New york & mainz, germany--(business wire)--pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) announced today that the european commission (ec) has granted a conditional marketing authorization (cma) to pfizer and biontech for comirnaty® (also known as bnt162b2), for active immunization to prevent covid-19 caused by sars-cov-2 virus, in individuals 16 years of age and older. this follows the european medicines agency's (ema) committee for medicinal products for human use (chmp) positive op
BNTX Ratings Summary
BNTX Quant Ranking